CVM · AMEX
Cel-Sci (CVM) Stock Price & Fundamentals
Cel-Sci (CVM) closed at $314.92 on Oct 9, 2026, up 1.03% from the previous close of $311.71.
Share price, past year
1Y +30.05%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $314.92 |
| Sep 30, 2026 | $307.71 |
| Aug 31, 2026 | $286.95 |
| Jul 31, 2026 | $271.95 |
| Jun 30, 2026 | $263.59 |
| May 29, 2026 | $259.41 |
| Apr 30, 2026 | $269.12 |
| Mar 31, 2026 | $272.31 |
| Feb 27, 2026 | $269.73 |
| Jan 30, 2026 | $268.86 |
| Dec 31, 2025 | $262.26 |
| Nov 28, 2025 | $255.21 |
| Oct 31, 2025 | $245.55 |
Key statistics
- Market cap
- $5.54B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.15
- Revenue (TTM)
- —
- Net income (TTM)
- −$22.70M
- Shares outstanding
- 17.6M
- Dividend yield
- —
- 52-week range
- $234.14 – $314.92
Cel-Sci's market cap is $5.54B, based on a share price of $314.92 and 17.6M shares outstanding as of Jun 30, 2026.
Financials
Cel-Sci reported revenue of $264.03K for fiscal 2014, up 65.45% from fiscal 2013.
Cel-Sci reported a net loss of $25.41M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2014ended Sep 30, 2014 | $264.03K | +65.5% | — | — | — | — |
| FY2013ended Sep 30, 2013 | $159.58K | −37.3% | — | — | — | — |
| FY2012ended Sep 30, 2012 | $254.61K | −73.4% | — | — | — | — |
| FY2011ended Sep 30, 2011 | $956.15K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2014ended Sep 30, 2014 | $67.82K | — | — |
| Q3 FY2014ended Jun 30, 2014 | $15.91K | — | — |
| Q2 FY2014ended Mar 31, 2014 | $67.16K | — | — |
| Q1 FY2014ended Dec 31, 2013 | $113.14K | — | — |
| Q4 FY2013ended Sep 30, 2013 | $15.45K | — | — |
| Q3 FY2013ended Jun 30, 2013 | $113.73K | — | — |
| Q2 FY2013ended Mar 31, 2013 | $15.41K | — | — |
| Q1 FY2013ended Dec 31, 2012 | $15.00K | — | — |
Company profile
- Name
- Cel-Sci Corporation
- Ticker
- CVM
- Exchange
- AMEX
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 8229 Boone Blvd ., Suite 802, Vienna, VA 22182
- Incorporated in
- CO
- Fiscal year ends
- September
- SEC CIK
- 0000725363
Recent SEC filings
- Aug 17, 2026
- Aug 14, 2026
- Jun 16, 2026
- May 15, 2026
- May 14, 2026
- May 13, 2026
- Feb 17, 2026
- Dec 29, 2025
Frequently asked questions
What is Cel-Sci's stock price?
Cel-Sci (CVM) closed at $314.92 on Oct 9, 2026, up 1.03% from the previous close of $311.71.
What is Cel-Sci's market cap?
Cel-Sci's market cap is $5.54B, based on a share price of $314.92 and 17.6M shares outstanding as of Jun 30, 2026.
How much revenue does Cel-Sci make?
Cel-Sci reported revenue of $264.03K for fiscal 2014, up 65.45% from fiscal 2013.
Does Cel-Sci pay a dividend?
Cel-Sci's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Cel-Sci Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures